BGAI
UTHR icon

Bruce G. Allen Investments’s United Therapeutics UTHR Stock Holding History

Bruce G. Allen Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75K Hold
18
– – 0.01% 490
2026
Q1 		$10.7K Hold
18
– – 0.01% 473
2025
Q4 		$8.77K Hold
18
– – 0.01% 492
2025
Q3 		$7.55K Hold
18
– – 0.01% 504
2025
Q2 		$5.17K Hold
18
– – ﹤0.01% 562
2025
Q1 		$5.55K Hold
18
– – ﹤0.01% 550
2024
Q4 		$6.35K Sell
18
-2
-10% -$735 0.01% 551
2024
Q3 		$7.17K Buy
20
+2
+11% +$676 0.01% 525
2024
Q2 		$5.73K Buy
+18
New +$4.76K ﹤0.01% 548
2024
Q1 		– Sell
-1
Closed -$220 – 1037
2023
Q4 		$220 Buy
+1
New +$230 ﹤0.01% 982

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bruce G. Allen Investments's UTHR Position: Q2 2026 in Review

Bruce G. Allen Investments held its United Therapeutics (UTHR) position steady in Q2 2026 at 18 shares worth $9.75K. The position accounts for 0.01% of the portfolio, ranked #490.

Bruce G. Allen Investments first reported a position in UTHR in Q4 2023 and has held it in 10 quarters since. The position peaked at $10.7K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bruce G. Allen Investments held 18 shares of United Therapeutics worth $9.75K as of Q2 2026.
  • Bruce G. Allen Investments left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of Bruce G. Allen Investments's portfolio in Q2 2026, its #490 holding.
  • Bruce G. Allen Investments first reported a position in United Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's United Therapeutics position peaked at $10.7K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.